- Home
- COYA vs ONL Comparison
COYA vs ONL Comparison
Compare COYA & ONL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COYA | ONL |
|---|---|---|
| Founded | 2020 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.6M | 149.2M |
| IPO Year | 2022 | 2021 |
Fundamental Metrics
Financial Performance| Metric | COYA | ONL |
|---|---|---|
| Price | $4.00 | $2.18 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $15.80 | $3.00 |
| AVG Volume (30 Days) | 120.6K | ★ 325.9K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.67% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $7,945,753.00 | ★ $147,647,000.00 |
| Revenue This Year | N/A | $4.10 |
| Revenue Next Year | $1,050.79 | $3.10 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 123.57 | N/A |
| 52 Week Low | $3.71 | $1.46 |
| 52 Week High | $7.75 | $3.01 |
Technical Indicators
Market Signals| Indicator | COYA | ONL |
|---|---|---|
| Relative Strength Index (RSI) | 37.61 | 47.53 |
| Support Level | $3.94 | $1.96 |
| Resistance Level | $5.16 | $2.67 |
| Average True Range (ATR) | 0.25 | 0.11 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 30.92 | 57.78 |
Price Performance
Historical ComparisonAbout COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
About ONL Orion Office REIT Inc.
Orion Properties Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased on a single-tenant net lease basis to creditworthy clients. The portfolio of the company includes traditional office buildings, governmental offices, medical offices, laboratories, and others. The Company operates in one business segment: direct ownership and operation of commercial real estate.